DXCM · 8-K · 20261029PR000193
Revenue Guidance and Outlook
DEXCOM INC · 2026-10-29 · Importance 79 · Surprise 76 · No source text
Dexcom set fiscal 2026 revenue guidance at $5.20 billion to $5.25 billion, representing approximately 12% to 13% growth. The company reiterated non-GAAP gross margin guidance of approximately 64%. It raised non-GAAP operating margin guidance to approximately 24% and adjusted EBITDA margin guidance to approximately 32%.
Key facts
- Dexcom’s fiscal 2026 revenue guidance is $5.20 billion to $5.25 billion, approximately 12% to 13% growth. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | committed | +10.6% | Dexcom’s fiscal 2026 revenue guidance is $5.20 billion to $5.25 billion, approximately 12% to 13% growth. |